Document is current
Any future updates will be listed below
-
Authors
Okamoto, Haruki
Fujio, Kosuke
Nakamura, Sou https://orcid.org/0000-0002-5601-9777
Harada, Yasuo
Hayashi, Hideki
Higashi, Natsumi
Ninomiya, Atsushi
Tanaka, Ryota
Sugimoto, Naoshi
Takayama, Naoya https://orcid.org/0000-0001-6867-1677
Kaneda, Atsushi
Sawaguchi, Akira
Kato, Yoshikazu https://orcid.org/0000-0003-2072-1780
Eto, Koji https://orcid.org/0000-0002-5863-7122
-
Funding
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP20bm0704051, JP23bm1323001, JP23bm1323001)
MEXT | Japan Society for the Promotion of Science (KIBAN S, 21H05047, 23K18299, 22K18169)
the CiRA Foundation Fund Otsuka Pharmaceutical Co., Ltd. Megakaryon Corporation Satake Multimix Corporation
JST FOREST Program JPMJFR225K
- License Information
-
More Information
Article History
Received: 6 November 2022
Accepted: 10 May 2024
First Online: 17 June 2024
Competing interests
: The authors declare the following competing interests: H. Okamoto, S. Nakamura, Y. Kato, and K. Eto have applied for patents related to this manuscript. K.E. is a founder of Megakaryon Co. Ltd. and has currently no stock. Otsuka Pharmaceutical Co., Ltd., Megakaryon Co. Ltd., and Satake Multimix Corporation provided collaborating project funding for this study (to K.E.). The interests of K.E. were reviewed and are managed by Kyoto University in accordance with its conflict-of-interest policies.
